DEVELOPING NOVEL IMMUNOTHERAPY TO SUPPRESS CANCER METASTASIS AND RECURRENCE IN BONE

$1,419,356FY2021Defense Health AgencyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →